top of page

SOLD: Medical cannabis distributor with GDP & controlled drugs licences in Germany & UK

Gain immediate access to global distribution channels by acquiring this Germany- & UK-based medical cannabis wholesaler and distributor – a highly desirable strategic ‘chess piece’ as the global cannabis supply chain continues to expand

Listing ID:


Licence(s) Held:

Germany: Wholesale Distribution Authorization, GDP certificate, Controlled Drug Licence for medical cannabis products, Irradiation (AmRadV) licences

United Kingdom: Wholesale Distribution Authorization, GDP certificate, Controlled Drug Licence for medical cannabis products

Cannabis Business - Active Buyers & Investors - Merger & Acquisition Opportunity

Listing Details:

  • A licensed wholesaler specializing in medical cannabis distribution, operating with a lean business structure and established in both Germany and the UK, complying with controlled drugs and GDP requirements

  • Currently undertaking import/export, wholesale sales, sales distribution (pharmacies) of medical cannabis flowers & extracts and medical CBD API, as well as B2B and B2C sales of proprietary THC/CBD test kits

  • Developed and patented THC/CBD test kits and built a diverse product portfolio that includes flowers, extracts, and CBD isolate

  • A well-established customer base and has a distinctive online shop for customers, along with an online portal for doctors and pharmacists. The portal is designed to provide useful information about cannabis products and access to helpful tools and services

  • Strategically partnered with EU-GMP certified warehouse providers to support the labelling of flower, extract and CBD products, and fulfill orders for the EU market

  • Experienced, industry-leading team with deep German market expertise as well as navigating global medical cannabis and CBD markets

  • Includes IP/proprietary products and one brand as part of the sale

  • Comes complete with supply agreements and B2B contracts in place

  • An acquiring entity has the potential to benefit from its tax loss carry forward asset, which currently exceeds €3.2 million ($4.7 million CAD)

  • For clarity, the transaction would include both the German and UK businesses as one

bottom of page